Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

KRX/377740 stock hub

KRX/377740 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/377740is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

503.6B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/377740

In the news

Latest news · KRX/377740

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-5.6

P25 -17.1P50 0.7P75 8.5

ROIC1.3

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/377740 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

KRW

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	298
Enterprise value	KRW 167.5B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Medical Devices
Last refreshed	2026-05-10
Market cap	KRW 503.6B
Price	KRW 4,985
Price currency	KRW
Rev Per Employee	397,058,873.15x
Sector	Healthcare
Sic	2835
Symbol	krx/377740
Website	https://www.bionote.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.37%
EV Earnings	-1.91x
EV/EBIT	9.96x
EV/EBITDA	6.43x
EV/FCF	26.71x
EV/Sales	1.42x
FCF yield	1.24%
P/B ratio	0.33x
P/S ratio	4.26x
PE Ratio3 Y	10.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.21%
EBITDA Margin	22%
FCF margin	5.3%
Gross margin	55.5%
Gross Profit	KRW 65.7B
Gross Profit Growth	28.84%
Gross Profit Growth Q	12.5%
Gross Profit Growth3 Y	-42.22%
Gross Profit Growth5 Y	-35.31%
Net Income	KRW -87.5B
Pretax Margin	-74.01%
Profit Margin	-73.95%
Profit Per Employee	KRW -293.6M
ROA	0.65
Roa5y	7.15
ROCE	1.09
ROE	-5.56
Roe5y	17.77
ROIC	1.33
Roic5y	16.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.83%
Cagr3y	-3.17%
FCF Growth	-86.79%
FCF Growth Q	-82.86%
FCF Growth3 Y	-68.82%
FCF Growth5 Y	-50.6%
OCF Growth	-75.17%
OCF Growth Q	-79.17%
OCF Growth3 Y	-61.35%
OCF Growth5 Y	-43.04%
Revenue Growth	15.12x
Revenue Growth Q	13.05x
Revenue Growth3 Y	-37.28x
Revenue Growth5 Y	-28.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.07
Assets	KRW 1.6T
Cash	KRW 339.8B
Current Assets	KRW 406.8B
Current Liabilities	KRW 13.1B
Debt	KRW 3.7B
Debt EBITDA	KRW 0.14
Debt Equity	KRW 0
Debt FCF	KRW 0.58
Equity	KRW 1.5T
Interest Coverage	58.54
Liabilities	KRW 44.6B
Long Term Assets	KRW 1.1T
Long Term Liabilities	KRW 31.5B
Net Cash	KRW 336.2B
Net Cash By Market Cap	KRW 66.75
Net Cash Growth	-16.27%
Net Debt EBITDA	KRW -12.91
Net Debt Equity	KRW -0.22
Net Debt FCF	KRW -53.61
Tangible Book Value	KRW 1.5T
Tangible Book Value Per Share	KRW 14,955
WACC	8.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	31.01
Inventory Turnover	2
Net Working Capital	KRW 55.4B
Quick ratio	28.69
Working Capital	KRW 393.7B
Working Capital Turnover	KRW 0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.79%
Dividend Growth	14%
Dividend Growth Years	0%
Dividend per share	KRW 200
Dividend Years	3
Dividend Yield	4.01%
Ex Div Date	2026-03-30
Last Dividend	KRW 228

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.82%
200-day SMA	5,498.9
3Y total return	-9.22%
50-day SMA	5,237.5
50-day SMA vs 200-day SMA	50under200
All Time High	11,700
All Time High Change	-57.39%
All Time High Date	2022-12-22
All Time Low	3,800
All Time Low Change	31.18%
All Time Low Date	2023-10-31
ATR	134.2
Beta	0.7
Beta1y	0.26
Beta2y	0.19
Ch YTD	-8.87
High	5,080
High52	6,320
High52 Date	2025-09-10
High52ch	-21.12%
Low	4,905
Low52	4,435
Low52 Date	2025-05-09
Low52ch	12.4%
Ma50ch	-4.82%
Price vs 200-day SMA	-9.35%
RSI	40.17
RSI Monthly	41.85
RSI Weekly	40.53
Sharpe ratio	0.45x
Sortino ratio	0.85
Total Return	4.8%
Tr YTD	-4.91
Tr1m	2.78%
Tr1w	-1.29%
Tr3m	-6.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 16.8B
Operating Income Growth	37.58
Operating Income Growth Q	-62.69
Operating Income Growth3 Y	-61.54
Operating Income Growth5 Y	-50.37
Operating margin	14.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,281,350%
Net Borrowing	-1,281,540,420
Shares Insiders	59.21%
Shares Institutions	0.26%
Shares Out	101,031,246
Shares Qo Q	-0.38%
Shares Yo Y	-0.79%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 6B
Average Volume	64,186x
Bv Per Share	14,987.9
CAPEX	KRW -8.1B
Ch1m	2.78
Ch1w	-1.29
Ch1y	9.08
Ch3m	-10.02
Ch3y	-20.24
Ch6m	-10.82
Change	0%
Change From Open	-1.68
Close	4,985
Days Gap	1.71
Depreciation Amortization	9,227,328,000
Dollar Volume	378,107,265
Earnings Date	2026-05-15
EBIT	KRW 16.8B
EBITDA	KRW 26B
EPS	KRW -865
F Score	6
FCF	KRW 6.3B
FCF EV Yield	3.74x
FCF Per Share	KRW 62.06
Financing CF	-26,554,560,390
Fiscal Year End	December
Founded	2,003
Goodwill	677,681,000
Income Tax	KRW -70.3M
Investing CF	-78,011,262,860
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Ma150	5,478.4
Ma150ch	-9.01%
Ma20	5,077.5
Ma20ch	-1.82%
Net CF	-89,470,052,820
Next Earnings Date	2026-05-15
Open	5,070
P FCF Ratio	80.32
P OCF Ratio	35.02
Payment Date	2026-04-16
Position In Range	45.71
Ppne	84,810,010,630
Price Date	2026-05-08
Price EBITDA	KRW 19.34
Ptbv Ratio	0.33
Relative Volume	1.18x
Revenue	118,323,544,200x
SBC By Revenue	0.22x
Share Based Comp	264,798,000
Tax By Revenue	-0.06x
Tr6m	-6.95%
Volume	75,849
Z Score	8.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/377740 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.0%

$200 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+4.8%

Next ex-dividend date: 2026-03-30

Performance

KRX/377740 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/377740?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+59.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

KRX/377740 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.2

Neutral momentum band

Price vs 200-day MA

-9.3%

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/377740

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/377740 stock rating?

krx/377740 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/377740 analysis?

The full report lives at /stocks/krx/377740/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/377740?

The latest report frames krx/377740 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/377740 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.